RTH-26140-37981
3 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 493 / MI
- Registered
- 2021-10-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-10-22
Registered in v-safe
-
2021-10-22
Dose 3 — Pfizer-BioNTech
- 2021-10-22
- 2021-10-23
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-11-07
- 2021-11-12
- 2021-11-19
-
2021-11-26
Survey response — day 35, dose 3MedDRA: Chills, Headache, Nasal congestion, Pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Aches, chills, headache, nasal and chest congestionMedDRA releases: 2024-11 · check-in free text available
- 2021-12-03
- 2022-01-21
- 2022-04-22
- 2022-10-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | No |
| 2 | 2021-01-05 | Pfizer-BioNTech | No |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 3
Symptoms: Aches, chills, headache, nasal and chest congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release